Anti-proliferative and anti-inflammatory effect of glucocorticoids in nasal mucosa and nasal polyp fibroblasts Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010
Does ozone cause an inflammation on nasal mucosa? Source: Eur Respir J 2006; 28: Suppl. 50, 671s Year: 2006
Increased expression of IL-19 in metaplastic epithelium of patients with chronic rhinosinusitis and nasal polyps Source: Annual Congress 2011 - Epithelial cell biology Year: 2011
Changes in human nasal mucosal innervation in environmentally triggered hyperreflectoric rhinitis Source: Eur Respir J 2003; 22: Suppl. 45, 119s Year: 2003
Lipopolysacharide modulates glucocorticoid receptor function in nasal mucosa and polyp fibroblasts Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013
Characterization of omalizumab partitioning in the nasal mucosa of patients Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies Year: 2019
Role of non cholinergic system components in chronic rhinosinusitis and nasal polyps Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010
Increased nasal mucosal swelling in subjects with asthma Source: Eur Respir J 2001; 18: Suppl. 33, 427s Year: 2001
Cox-2 regulation by IL-1β through MAPKs: A comparison of nasal mucosa and nasal polyps fibroblasts from AIA patients Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010
Pathophysiology of airway hyperresponsiveness in patients with nasal polyposis Source: Annual Congress 2011 - Phenotyping airway diseases Year: 2011
Nasal mucosa biopsy in patients with severe bronchial asthma Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Effect of mepolizumab on chronic rhinosinusitis symptoms and nasal hypersensitivity in patients with or without nasal polyps Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020
Impact of biologic therapy in severe asthma with nasal polyps Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021
NOTCH-1 activation sustains hyperexpression of IL-33 in the epithelium of nasal polyps Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017
Intranasal steroids decrease eosinophils but not mucin expression in nasal polyps Source: Eur Respir J 2004; 24 : 594-600 Year: 2004
Hairy polyps of the nasopharynx – a rare cause of upper airway obstruction Source: Eur Respir J 2004; 24: Suppl. 48, 398s Year: 2004
SPLUNC1, a putative mediator of host defence, is predominantly localised in the mucous gland cells of the upper airways, nose and oral cavity Source: Eur Respir J 2004; 24: Suppl. 48, 554s Year: 2004
Peculiarities of cytokine concentration in patients with nasal polyposis and asthmatic triad Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics Year: 2018
Human nasal and bronchial airway epithelial cell comparisons: ciliary beat frequency and zinc homeostasis Source: Eur Respir J 2004; 24: Suppl. 48, 555s Year: 2004